<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Kidney Function &#187; Journal of Vascular Surgery</title>
	<atom:link href="http://kidneyfunction.org/author/journal-of-vascular-surgery/feed/" rel="self" type="application/rss+xml" />
	<link>http://kidneyfunction.org</link>
	<description>Renal Information</description>
	<lastBuildDate>Sun, 22 Jan 2012 23:48:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.2</generator>
		<item>
		<title>Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: The V-HEALTH study</title>
		<link>http://kidneyfunction.org/multicenter-phase-iii-trial-of-the-safety-of-allogeneic-endothelial-cell-implants-after-the-creation-of-arteriovenous-access-for-hemodialysis-use-the-v-health-study/</link>
		<comments>http://kidneyfunction.org/multicenter-phase-iii-trial-of-the-safety-of-allogeneic-endothelial-cell-implants-after-the-creation-of-arteriovenous-access-for-hemodialysis-use-the-v-health-study/#comments</comments>
		<pubDate>Mon, 30 Nov 2009 23:00:00 +0000</pubDate>
		<dc:creator>Journal of Vascular Surgery</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://3050960</guid>
		<description><![CDATA[Conclusions: Targeted local therapy with perivascular, allogeneic endothelial cells is a safe and novel therapeutic approach that may be ideally suited to control the response to injury at surgical anastomoses. Larger randomized trials are needed to determine if Vascugel can prolong AVG or AVF patency. (Source: Journal of Vascular Surgery)]]></description>
			<content:encoded><![CDATA[<p>Conclusions: Targeted local therapy with perivascular, allogeneic endothelial cells is a safe and novel therapeutic approach that may be ideally suited to control the response to injury at surgical anastomoses. Larger randomized trials are needed to determine if Vascugel can prolong AVG or AVF patency. (Source: Journal of Vascular Surgery)</p>
]]></content:encoded>
			<wfw:commentRss>http://kidneyfunction.org/multicenter-phase-iii-trial-of-the-safety-of-allogeneic-endothelial-cell-implants-after-the-creation-of-arteriovenous-access-for-hemodialysis-use-the-v-health-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

